Chad A. Lewis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chad A. Lewis has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Scott J. Miller
Yale University
6 shared publications - Matthew J. Moschitto
Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, 163 Frelinghuysen Road, Piscataway, New Jersey 08854, United States
5 shared publications David N. Vaccarello
Department of Chemistry and Chemical Biology, Baker Laboratory, Cornell University, Ithaca, NY 14853, USA
4 shared publications- Phil S. Baran
Department of Chemistry, Scripps Research, La Jolla, USA
4 shared publications Anil M. Rane
Chemical Research and Development, Pfizer Inc., Groton, Connecticut06340, United States
2 shared publicationsAnna Chiu
Department of Chemistry, Yale University, New Haven, Connecticut 06520, and Merck Research Laboratories, Rahway, New Jersey 07065
2 shared publications
Latest Publications
- Open Access
- 14 June 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110382
Characterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonance
- 14 June 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110382
Open AccessCharacterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonance
- 3 February 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (12) , 2223-2239
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
Lufotrelvir was designed as a first in class 3CL protease inhibitor to treat COVID-19. Development of lufotrelvir was challenged by its relatively poor stability due to its propensity to epimerize and degrade. Key elements of process development included improvement of the supply routes to the indole and lactam fragments, a Claisen addition to homologate the lactam, and a subsequent phosphorylation reaction to prepare the prodrug as well as identification of a DMSO solvated form of lufotrelvir to enable long-term storage. As a new approach to preparing the indole fragment, a Cu-catalyzed C-O coupling using oxalamide ligands was demonstrated. The control of process-related impurities was essential to accommodate the parenteral formulation. Isolation of an MEK solvate followed by the DMSO solvate ensured that all impurities were controlled appropriately.
- 3 February 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (12) , 2223-2239
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
Lufotrelvir was designed as a first in class 3CL protease inhibitor to treat COVID-19. Development of lufotrelvir was challenged by its relatively poor stability due to its propensity to epimerize and degrade. Key elements of process development included improvement of the supply routes to the indole and lactam fragments, a Claisen addition to homologate the lactam, and a subsequent phosphorylation reaction to prepare the prodrug as well as identification of a DMSO solvated form of lufotrelvir to enable long-term storage. As a new approach to preparing the indole fragment, a Cu-catalyzed C-O coupling using oxalamide ligands was demonstrated. The control of process-related impurities was essential to accommodate the parenteral formulation. Isolation of an MEK solvate followed by the DMSO solvate ensured that all impurities were controlled appropriately.
- 21 September 2021
- Published by Springer Nature in Nature Catalysis
- Vol. 4 (9) , 775-782
Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor
- 21 September 2021
- Published by Springer Nature in Nature Catalysis
- Vol. 4 (9) , 775-782
Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor
- 18 September 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (3) , 608-615
Development of a Nitrene-Type Rearrangement for the Commercial Route of the JAK1 Inhibitor Abrocitinib
- 18 September 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (3) , 608-615
Development of a Nitrene-Type Rearrangement for the Commercial Route of the JAK1 Inhibitor Abrocitinib
- 6 October 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (28) , 4773-4777
Synthesis of the Rubiyunnanin B Core Aglycon
Rubiyunnanin B possesses an intriguing anticancer profile whose activity is dependent on the glycosylation of a fused tyrosinyl residue. We have developed a rapid synthesis of the rubiyunnanin B dityrosine core using a Suzuki coupling. Furthermore, the atropisomeric and isomeric products obtained were identified and their distribution controlled. The two major products obtained from the dityrosine coupling were discovered to be locked cis/trans isomers of the internal amide with atropisomerization quantifiable on the NMR timescale.
- 6 October 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (28) , 4773-4777
Synthesis of the Rubiyunnanin B Core Aglycon
Rubiyunnanin B possesses an intriguing anticancer profile whose activity is dependent on the glycosylation of a fused tyrosinyl residue. We have developed a rapid synthesis of the rubiyunnanin B dityrosine core using a Suzuki coupling. Furthermore, the atropisomeric and isomeric products obtained were identified and their distribution controlled. The two major products obtained from the dityrosine coupling were discovered to be locked cis/trans isomers of the internal amide with atropisomerization quantifiable on the NMR timescale.
- 8 April 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (9) , 3744-3751
Discovery and Development of a Three-Component Oxidopyrylium [5 + 2] Cycloaddition
α-Hydroxy-γ-pyrone-based oxidopyrylium cycloaddition reactions are useful methods for accessing a highly diverse range of oxabicyclo[3.2.1]octane products. Intermolecular variants of the reaction require the formation of a methyl triflate-based pre-ylide salt that upon treatment with base in the presence of alkenes or alkynes leads to α-methoxyenone-containing bicyclic products. Herein, we describe our discovery that the use of ethanol-stabilized chloroform as solvent leads to the generation of α-ethoxyenone-containing bicyclic byproducts. This three-component process was further optimized by gently heating a mixture of a purified version of the oxidopyrylium dimer in the presence of an alcohol prior to addition of a dipolarophile. Using this convenient procedure, several new oxidopyrylium cycloaddition products can be generated in moderate yields. We also highlight the method in a tandem ring-opening/debenzylation method for the generation of α-hydroxytropolones.
- 8 April 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (9) , 3744-3751
Discovery and Development of a Three-Component Oxidopyrylium [5 + 2] Cycloaddition
α-Hydroxy-γ-pyrone-based oxidopyrylium cycloaddition reactions are useful methods for accessing a highly diverse range of oxabicyclo[3.2.1]octane products. Intermolecular variants of the reaction require the formation of a methyl triflate-based pre-ylide salt that upon treatment with base in the presence of alkenes or alkynes leads to α-methoxyenone-containing bicyclic products. Herein, we describe our discovery that the use of ethanol-stabilized chloroform as solvent leads to the generation of α-ethoxyenone-containing bicyclic byproducts. This three-component process was further optimized by gently heating a mixture of a purified version of the oxidopyrylium dimer in the presence of an alcohol prior to addition of a dipolarophile. Using this convenient procedure, several new oxidopyrylium cycloaddition products can be generated in moderate yields. We also highlight the method in a tandem ring-opening/debenzylation method for the generation of α-hydroxytropolones.
- 5 November 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (22) , 11258-11265
Access to the Surugatoxin Alkaloids: Chemo-, Regio-, and Stereoselective Oxindole Annulation
We report the synthesis of an aglycone of the surugatoxin family. The synthesis of this surugatoxin core was accomplished in 13 steps using a new oxindole annulation and late-stage enamine oxidation.
- 5 November 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (22) , 11258-11265
Access to the Surugatoxin Alkaloids: Chemo-, Regio-, and Stereoselective Oxindole Annulation
We report the synthesis of an aglycone of the surugatoxin family. The synthesis of this surugatoxin core was accomplished in 13 steps using a new oxindole annulation and late-stage enamine oxidation.
- 24 August 2015
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 26 (18) , 2473-2478
Allylic Oxide Regio-Resolution as a Tool for the Synthesis and Transfer of Carbasugars
We report a method for the synthesis and transfer of carbasugars, a prevalent moiety throughout biology. This approach relies on the formation of diastereomeric π-allyl intermediates generated from racemic allylic oxide progenitors. Ligand directed nucleophilic attack occurs on the complexes resulting in enantioenriched regioisomers. This allowed for the generation of enantioenriched carbasugars from commodity chemicals. It is envisioned that by using the appropriate allylic oxide, ligand, and phenolic donor that any stereoarray of the carbasugars may be accessed and appended onto phenolic natural products.
- 24 August 2015
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 26 (18) , 2473-2478
Allylic Oxide Regio-Resolution as a Tool for the Synthesis and Transfer of Carbasugars
We report a method for the synthesis and transfer of carbasugars, a prevalent moiety throughout biology. This approach relies on the formation of diastereomeric π-allyl intermediates generated from racemic allylic oxide progenitors. Ligand directed nucleophilic attack occurs on the complexes resulting in enantioenriched regioisomers. This allowed for the generation of enantioenriched carbasugars from commodity chemicals. It is envisioned that by using the appropriate allylic oxide, ligand, and phenolic donor that any stereoarray of the carbasugars may be accessed and appended onto phenolic natural products.
- 1 May 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (10) , 5252-5259
Regiodivergent Addition of Phenols to Allylic Oxides
The regiodivergent addition of substituted phenols to allylic oxides has been demonstrated using C2-symmetric palladium complexes. Complex phenol donors tyrosine, estradiol, and griseofulvin follow the predictive model.
- 1 May 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (10) , 5252-5259
Regiodivergent Addition of Phenols to Allylic Oxides
The regiodivergent addition of substituted phenols to allylic oxides has been demonstrated using C2-symmetric palladium complexes. Complex phenol donors tyrosine, estradiol, and griseofulvin follow the predictive model.
- 9 March 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (6) , 3339-3342
Syntheses of Arnottin I and Arnottin II
Short total syntheses of arnottin I and II were accomplished in 5 and 6 steps, respectively. A sesamol-benzyne cycloaddition with a 3-furyl-benzoate followed by regiospecific lactonization provided rapid, large-scale access to the core of arnottin I. Saponification of arnottin I and hypervalent iodide mediated spirocyclization provided an efficient and direct preparation of racemic arnottin II.
- 9 March 2015
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 80 (6) , 3339-3342
Syntheses of Arnottin I and Arnottin II
Short total syntheses of arnottin I and II were accomplished in 5 and 6 steps, respectively. A sesamol-benzyne cycloaddition with a 3-furyl-benzoate followed by regiospecific lactonization provided rapid, large-scale access to the core of arnottin I. Saponification of arnottin I and hypervalent iodide mediated spirocyclization provided an efficient and direct preparation of racemic arnottin II.